EMA recommends new antibiotic

Friday 23 September 2011

The European Medicines Agency is recommending approval of a new macrocyclic antibiotic for Clostridium difficile, Dificlir (fidaxomicin). Developed by Optimer Pharmaceuticals Inc, the antibiotic was approved by the FDA in May 2011.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom